These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1892 related articles for article (PubMed ID: 33508291)

  • 1. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
    Aghbash PS; Eslami N; Shamekh A; Entezari-Maleki T; Baghi HB
    Life Sci; 2021 Apr; 270():119124. PubMed ID: 33508291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell checkpoint regulators in the heart.
    Grabie N; Lichtman AH; Padera R
    Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection.
    Rutigliani M; Bozzo M; Barberis A; Greppi M; Anelli E; Castellaro L; Bonsignore A; Azzinnaro A; Pesce S; Filauro M; Rollandi GA; Castagnola P; Candiani S; Marcenaro E
    Front Immunol; 2022; 13():849140. PubMed ID: 35222440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity.
    Beserra DR; Alberca RW; Branco ACCC; de Mendonça Oliveira L; de Souza Andrade MM; Gozzi-Silva SC; Teixeira FME; Yendo TM; da Silva Duarte AJ; Sato MN
    J Immunol Res; 2022; 2022():9764002. PubMed ID: 35971391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection.
    Sperk M; Domselaar RV; Neogi U
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Dysregulation in COVID-19 Patients.
    Sabbatino F; Conti V; Franci G; Sellitto C; Manzo V; Pagliano P; De Bellis E; Masullo A; Salzano FA; Caputo A; Peluso I; Zeppa P; Scognamiglio G; Greco G; Zannella C; Ciccarelli M; Cicala C; Vecchione C; Filippelli A; Pepe S
    Front Immunol; 2021; 12():695242. PubMed ID: 34163490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.
    Aygun H
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):487-494. PubMed ID: 35099571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.
    Loretelli C; Abdelsalam A; D'Addio F; Ben Nasr M; Assi E; Usuelli V; Maestroni A; Seelam AJ; Ippolito E; Di Maggio S; Loreggian L; Radovanovic D; Vanetti C; Yang J; El Essawy B; Rossi A; Pastore I; Montefusco L; Lunati ME; Bolla AM; Biasin M; Antinori S; Santus P; Riva A; Zuccotti GV; Galli M; Rusconi S; Fiorina P
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
    Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM
    PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors.
    Samiei A; Gjertson DW; Memarzadeh S; Konecny GE; Moatamed NA
    Diagn Pathol; 2022 Sep; 17(1):70. PubMed ID: 36104728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the PD-1 and PD-L1 axis in COVID-19.
    R Bonam S; Hu H; Bayry J
    Future Microbiol; 2022 Sep; 17():985-988. PubMed ID: 35899493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction.
    Eljaafari A; Pestel J; Le Magueresse-Battistoni B; Chanon S; Watson J; Robert M; Disse E; Vidal H
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
    Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative.
    Patel SS; Weirather JL; Lipschitz M; Lako A; Chen PH; Griffin GK; Armand P; Shipp MA; Rodig SJ
    Blood; 2019 Dec; 134(23):2059-2069. PubMed ID: 31697809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation.
    Xu Z; Tsai HI; Xiao Y; Wu Y; Su D; Yang M; Zha H; Yan F; Liu X; Cheng F; Chen H
    ACS Nano; 2020 Jul; 14(7):7959-7969. PubMed ID: 32515579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
    Huang HC; Wang SH; Fang GC; Chou WC; Liao CC; Sun CP; Jan JT; Ma HH; Ko HY; Ko YA; Chiang MT; Liang JJ; Kuo CT; Lee TA; Morales-Scheihing D; Shen CY; Chen SY; McCullough LD; Cui L; Wernig G; Tao MH; Lin YL; Chang YM; Wang SP; Lai YJ; Li CW
    J Med Virol; 2023 Feb; 95(2):e28478. PubMed ID: 36609964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble immune checkpoints CTLA-4, HLA-G, PD-1, and PD-L1 are associated with endometriosis-related infertility.
    Santoso B; Sa'adi A; Dwiningsih SR; Tunjungseto A; Widyanugraha MYA; Mufid AF; Rahmawati NY; Ahsan F
    Am J Reprod Immunol; 2020 Oct; 84(4):e13296. PubMed ID: 32593225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.